DTL
ALXN

Dynamic Technology Lab’s Alexion Pharmaceuticals ALXN Stock Holding History

Dynamic Technology Lab’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,184
Closed -$1.69M – 1649
2021
Q2 		$1.69M Sell
9,184
-56,124
-86% -$9.63M 0.17% 162
2021
Q1 		$9.99M Buy
65,308
+58,232
+823% +$9.01M 1.13% 6
2020
Q4 		$1.11M Buy
+7,076
New +$909K 0.18% 148
2020
Q2 		– Sell
-4,900
Closed -$440K – 1482
2020
Q1 		$440K Buy
4,900
+1,741
+55% +$171K 0.09% 416
2019
Q4 		$342K Sell
3,159
-7,301
-70% -$781K 0.05% 616
2019
Q3 		$1.02M Buy
+10,460
New +$1.18M 0.18% 148
2019
Q2 		– Sell
-4,715
Closed -$637K – 1410
2019
Q1 		$637K Sell
4,715
-6,346
-57% -$789K 0.1% 321
2018
Q4 		$1.08M Buy
+11,061
New +$1.31M 0.19% 145
2018
Q2 		– Sell
-2,300
Closed -$257K – 1451
2018
Q1 		$257K Buy
+2,300
New +$275K 0.04% 774
2017
Q4 		– Sell
-2,537
Closed -$357K – 1461
2017
Q3 		$357K Buy
+2,537
New +$345K 0.06% 617
2016
Q4 		– Sell
-3,600
Closed -$442K – 1264
2016
Q3 		$442K Sell
3,600
-1,324
-27% -$170K 0.12% 294
2016
Q2 		$575K Buy
+4,924
New +$699K 0.16% 199
2015
Q1 		– Sell
-1,268
Closed -$235K – 950
2014
Q4 		$235K Buy
+1,268
New +$235K 0.12% 401
2014
Q3 		– Sell
-3,043
Closed -$475K – 921
2014
Q2 		$475K Buy
+3,043
New +$480K 0.23% 120

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Dynamic Technology Lab's ALXN Position: Q3 2021 in Review

Dynamic Technology Lab sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 9,184 shares — an estimated $1.69M sold.

Dynamic Technology Lab first reported a position in ALXN in Q2 2014 and held it in 14 quarters. The position peaked at $9.99M in Q1 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Dynamic Technology Lab reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Dynamic Technology Lab sold 9,184 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.69M.
  • Dynamic Technology Lab first reported a position in Alexion Pharmaceuticals in Q2 2014 and held it in 14 quarters.
  • Dynamic Technology Lab's Alexion Pharmaceuticals position peaked at $9.99M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Dynamic Technology Lab's 13F filing for Q3 2021, filed 15 Nov 2021.